Monoamine oxidase inhibitors (MAO Inhibitors) are medications used to manage and treat depression, among other neurological and psychiatric illnesses. It is in the Antidepressants class of drugs. This activity reviews the indications, action, and contraindications of the commonly prescribed MAO Inhibitors as a valuable agent in managing depression and other neuropsychiatric disorders. This activity will highlight the mechanism of action, adverse event profile, and other key factors such as off-label use, administration, and relevant molecular interactions pertinent for the interprofessional team members involved in the care of patients with depression and related conditions.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/24736
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.5 hours
Nursing: 1.5 hours
Pharmacy: 1.5 hours - MOC Credit Details: ABS - 1.5 Point; Credit Type(s): Accredited CME (ABS)
ABPATH - 1.5 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABA - 1.5 Point; Credit Type(s): Lifelong Learning (ABA)
ABIM - 1.5 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.5 Point; Credit Type(s): Self-Assessment (ABS)
ABP - 1.5 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Adolescent Medicine, Ambulatory/Outpatient, Chemical Pathology, General Operative Anesthesia, General Pediatrics, General Surgery, Geriatric Medicine, Internal Medicine
Subscribe
Login
0 Comments
Oldest